SCHEMBL5598077

SCHEMBL5598077

COc1ccccc1NC(=O)c1cc(Br)ccc1NS(=O)(=O)c1ccc(Cl)c([N+](=O)[O-])c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.61
GAA P10253 3/20 0.61
POLB P06746 1/20 0.61
RECQL P46063 1/20 0.61
SLC10A2 Q12908 2/20 0.61
SLC10A1 Q14973 2/20 0.61
SLC10A6 Q3KNW5 2/20 0.61
SLC25A1 P53007 1/20 0.58
ALDH1A1 P00352 3/20 0.56
RORC P51449 1/20 0.55
DNMT1 P26358 2/20 0.55
PKM P14618 1/20 0.55
LMNA P02545 6/20 0.52
KMT2A Q03164 5/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
TDP1 Q9NUW8 4/20 0.52
MEN1 O00255 4/20 0.52
DNMT3A Q9Y6K1 1/20 0.51
MAPK1 P28482 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597948 0.84 ALDH1A1 (0.58) MAPTGAASLC10A2SLC10A1SLC10A6
SCHEMBL5598236 0.83 SLC10A6 (0.86) MAPTSLC10A2SLC10A1SLC10A6SLC25A1
SCHEMBL5597819 0.83 SLC25A1 (0.60) MAPTGAASLC10A2SLC10A1SLC10A6
SCHEMBL3611184 0.83 ALDH1A1 (0.80) MAPTGAASLC25A1ALDH1A1DNMT1
SCHEMBL30777866 0.82 SLC10A6 (0.75) MAPTSLC10A2SLC10A1SLC10A6SLC25A1
SCHEMBL27089455 0.82 SLC10A6 (0.75) MAPTSLC10A2SLC10A1SLC10A6SLC25A1
SCHEMBL5598202 0.80 ALDH1A1 (0.55) MAPTGAAPOLBSLC10A2SLC10A1
SCHEMBL5598392 0.80 SLC25A1 (0.64) MAPTSLC10A2SLC10A1SLC10A6SLC25A1
SCHEMBL5597716 0.78 ALDH1A1 (0.59) MAPTGAAPOLBSLC25A1ALDH1A1
SCHEMBL5597943 0.77 DNMT1 (0.65) MAPTGAAPOLBSLC25A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-7119120-B2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2006-10-10 US disclosed
EP-1465638-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2004-10-13 EP disclosed
US-20040019113-A1 Phosphate transport inhibitors GELTEX PHARMACEUTICALS, INC. 2004-01-29 US disclosed
WO-2003057225-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019113-A1 Phosphate transport inhibitors SLC34A1, SLC34A2, SLC20A1 MAPT 3148/4885GAA 535/4885POLB 2364/4885
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 MAPT 3058/4885GAA 536/4885POLB 2611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.